Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study
暂无分享,去创建一个
Örjan Smedby | Olof Dahlqvist Leinhard | Joel Kullberg | Lars Johansson | Torbjörn Lindström | Fredrik H. Nystrom | Stergios Kechagias | Håkan Ahlström | J. Kullberg | H. Ahlström | L. Johansson | F. Nystrom | O. D. Leinhard | Ö. Smedby | T. Lindström | S. Kechagias | J. Kihlberg | Johan Kihlberg | Sepehr Zanjani | Solveig Gjellan | Solveig Gjellan | S. Zanjani
[1] D. Kivlahan,et al. The AUDIT Alcohol Consumption Questions (AUDIT-C) An Effective Brief Screening Test for Problem Drinking , 2010 .
[2] D. Kivlahan,et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. , 1998, Archives of internal medicine.
[3] M. Bernardi,et al. Review article: alcoholic liver disease – pathophysiological aspects and risk factors , 2006, Alimentary pharmacology & therapeutics.
[4] G. Reaven. The metabolic syndrome: requiescat in pace. , 2005, Clinical chemistry.
[5] Vanhamme,et al. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.
[6] L. N. Valenti,et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes , 2008, Hepatology.
[7] K. Isselbacher,et al. EFFECT OF PROLONGED ETHANOL INGESTION ON THE TRANSPORT AND METABOLISM OF LIPIDS IN MAN. , 1965, The New England journal of medicine.
[8] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[9] AndrewJ. S. Coats. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.
[10] D. Graveron-Demilly,et al. Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.
[11] R. Torella,et al. Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. , 2005, Metabolism: clinical and experimental.
[12] The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. , 2006, Atherosclerosis.
[13] G. Bedogni,et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study , 2005, Hepatology.
[14] K. Bush,et al. Screening for problem drinking , 1998, Journal of general internal medicine.
[15] E. Forsum,et al. Validation of energy intake by dietary recall against different methods to assess energy expenditure. , 2004, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[16] W. Frishman. Effects of longterm fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialKeech A, and the FIELD study investigators (Univ of Sydney, Australia; et al) Lancet 366:1849–1861, 2005§ , 2007 .
[17] G Corrao,et al. Alcohol and coronary heart disease: a meta-analysis. , 2000, Addiction.
[18] C. García-Monzón,et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. , 2000, Journal of hepatology.
[19] P Glasziou,et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.
[20] M McCarthy,et al. Hepatology , 1999, Rapid Medicine.
[21] Luc,et al. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII , 1999, European journal of clinical investigation.
[22] S. Grundy,et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.
[23] P. Nilsson-ehle,et al. Prolonged administration of ethanol to young, healthy volunteers: effects on biochemical, morphological and neurophysiological parameters. , 1973, Acta medica Scandinavica. Supplementum.
[24] D A Follmann,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .
[25] J. Rouleau. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial. , 2005, The American journal of medicine.
[26] D. Grobbee,et al. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. , 2007, The New England journal of medicine.
[27] C. Roberts,et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. , 2008, The New England journal of medicine.
[28] G. Farrell,et al. Nonalcoholic fatty liver disease: From steatosis to cirrhosis , 2006, Hepatology.
[29] R. Bloigu,et al. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers. , 2009, Alcohol and alcoholism.
[30] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.
[31] S. Yusuf. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .
[32] P Christoffersen,et al. Long term prognosis of fatty liver: risk of chronic liver disease and death , 2004, Gut.
[33] E. Bonora,et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.
[34] G. Brandi,et al. Drinking habits as cofactors of risk for alcohol induced liver damage , 1997, Gut.
[35] G. Marchesini,et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.
[36] T. Sørensen,et al. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study , 1996, Hepatology.
[37] Alan D. Lopez,et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. , 1997, The New England journal of medicine.
[38] T. Dwyer,et al. Alcohol consumption and the risk of alcohol related cirrhosis in women. , 1987, British medical journal.
[39] J. George,et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss , 2009, Hepatology.
[40] R. Marfella,et al. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[41] Thomas F. Babor,et al. Alcohol Use Disorders Identification Test , 1995 .
[42] Y. Kawano. Physio-pathological effects of alcohol on the cardiovascular system: its role in hypertension and cardiovascular disease , 2010, Hypertension Research.
[43] D. Grobbee,et al. Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia , 2007 .
[44] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[45] Chris Day,et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.
[46] M. Holmqvist,et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.
[47] Peter Johnson,et al. Erythrocyte and plasma protein modification in alcoholism: a possible role of acetaldehyde. , 2006, Biochimica et biophysica acta.
[48] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[49] Ø. Braaten,et al. A daily glass of red wine: does it affect markers of inflammation? , 2005, Alcohol and alcoholism.
[50] M. de Lorgeril,et al. Cretan Mediterranean diet for prevention of coronary heart disease. , 1995, The American journal of clinical nutrition.
[51] P. Lundberg,et al. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects , 2008, Gut.